Global Gene Vector Supply, Demand and Key Producers, 2023-2029
The global Gene Vector market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Gene Vector demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Vector, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Vector that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Vector total market, 2018-2029, (USD Million)
Global Gene Vector total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Vector total market, key domestic companies and share, (USD Million)
Global Gene Vector revenue by player and market share 2018-2023, (USD Million)
Global Gene Vector total market by Vector Type, CAGR, 2018-2029, (USD Million)
Global Gene Vector total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Vector market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies and Spark Therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Vector market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Vector Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Vector Market, By Region:
1. How big is the global Gene Vector market?
2. What is the demand of the global Gene Vector market?
3. What is the year over year growth of the global Gene Vector market?
4. What is the total value of the global Gene Vector market?
5. Who are the major players in the global Gene Vector market?
6. What are the growth factors driving the market demand?
This report studies the global Gene Vector demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Vector, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Vector that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Vector total market, 2018-2029, (USD Million)
Global Gene Vector total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Vector total market, key domestic companies and share, (USD Million)
Global Gene Vector revenue by player and market share 2018-2023, (USD Million)
Global Gene Vector total market by Vector Type, CAGR, 2018-2029, (USD Million)
Global Gene Vector total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Vector market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies and Spark Therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Vector market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Vector Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Vector Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lentivirus
- Adenovirus
- Adeno-associated Virus (AAV)
- Plasmid DNA
- Others
- Scientific Research
- CRO
- CDMO
- Others (Pharmaceutical, Biotechnology Companies)
- Lonza
- Merck KGaA
- Oxford Biomedica
- CGT Catapult
- Charles River Laboratories
- uniQure N.V.
- FUJIFILM Diosynth Biotechnologies
- Spark Therapeutics, Inc.
1. How big is the global Gene Vector market?
2. What is the demand of the global Gene Vector market?
3. What is the year over year growth of the global Gene Vector market?
4. What is the total value of the global Gene Vector market?
5. Who are the major players in the global Gene Vector market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Vector Introduction
1.2 World Gene Vector Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Vector Total Market by Region (by Headquarter Location)
1.3.1 World Gene Vector Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Vector Market Size (2018-2029)
1.3.3 China Gene Vector Market Size (2018-2029)
1.3.4 Europe Gene Vector Market Size (2018-2029)
1.3.5 Japan Gene Vector Market Size (2018-2029)
1.3.6 South Korea Gene Vector Market Size (2018-2029)
1.3.7 ASEAN Gene Vector Market Size (2018-2029)
1.3.8 India Gene Vector Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Vector Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Vector Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Vector Consumption Value (2018-2029)
2.2 World Gene Vector Consumption Value by Region
2.2.1 World Gene Vector Consumption Value by Region (2018-2023)
2.2.2 World Gene Vector Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Vector Consumption Value (2018-2029)
2.4 China Gene Vector Consumption Value (2018-2029)
2.5 Europe Gene Vector Consumption Value (2018-2029)
2.6 Japan Gene Vector Consumption Value (2018-2029)
2.7 South Korea Gene Vector Consumption Value (2018-2029)
2.8 ASEAN Gene Vector Consumption Value (2018-2029)
2.9 India Gene Vector Consumption Value (2018-2029)
3 WORLD GENE VECTOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Vector Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Vector Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Vector in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Vector in 2022
3.3 Gene Vector Company Evaluation Quadrant
3.4 Gene Vector Market: Overall Company Footprint Analysis
3.4.1 Gene Vector Market: Region Footprint
3.4.2 Gene Vector Market: Company Product Type Footprint
3.4.3 Gene Vector Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Vector Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Vector Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Vector Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Vector Consumption Value Comparison
4.2.1 United States VS China: Gene Vector Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Vector Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Vector Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Vector Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Vector Revenue, (2018-2023)
4.4 China Based Companies Gene Vector Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Vector Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Vector Revenue, (2018-2023)
4.5 Rest of World Based Gene Vector Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Vector Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Vector Revenue, (2018-2023)
5 MARKET ANALYSIS BY VECTOR TYPE
5.1 World Gene Vector Market Size Overview by Vector Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Vector Type
5.2.1 Lentivirus
5.2.2 Adenovirus
5.2.3 Adeno-associated Virus (AAV)
5.2.4 Plasmid DNA
5.2.5 Others
5.3 Market Segment by Vector Type
5.3.1 World Gene Vector Market Size by Vector Type (2018-2023)
5.3.2 World Gene Vector Market Size by Vector Type (2024-2029)
5.3.3 World Gene Vector Market Size Market Share by Vector Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Vector Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Scientific Research
6.2.2 CRO
6.2.3 CDMO
6.2.4 Others (Pharmaceutical, Biotechnology Companies)
6.2.5 Others (Pharmaceutical, Biotechnology Companies)
6.3 Market Segment by Application
6.3.1 World Gene Vector Market Size by Application (2018-2023)
6.3.2 World Gene Vector Market Size by Application (2024-2029)
6.3.3 World Gene Vector Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Gene Vector Product and Services
7.1.4 Lonza Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Gene Vector Product and Services
7.2.4 Merck KGaA Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Oxford Biomedica
7.3.1 Oxford Biomedica Details
7.3.2 Oxford Biomedica Major Business
7.3.3 Oxford Biomedica Gene Vector Product and Services
7.3.4 Oxford Biomedica Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Oxford Biomedica Recent Developments/Updates
7.3.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.4 CGT Catapult
7.4.1 CGT Catapult Details
7.4.2 CGT Catapult Major Business
7.4.3 CGT Catapult Gene Vector Product and Services
7.4.4 CGT Catapult Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CGT Catapult Recent Developments/Updates
7.4.6 CGT Catapult Competitive Strengths & Weaknesses
7.5 Charles River Laboratories
7.5.1 Charles River Laboratories Details
7.5.2 Charles River Laboratories Major Business
7.5.3 Charles River Laboratories Gene Vector Product and Services
7.5.4 Charles River Laboratories Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Charles River Laboratories Recent Developments/Updates
7.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.6 uniQure N.V.
7.6.1 uniQure N.V. Details
7.6.2 uniQure N.V. Major Business
7.6.3 uniQure N.V. Gene Vector Product and Services
7.6.4 uniQure N.V. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 uniQure N.V. Recent Developments/Updates
7.6.6 uniQure N.V. Competitive Strengths & Weaknesses
7.7 FUJIFILM Diosynth Biotechnologies
7.7.1 FUJIFILM Diosynth Biotechnologies Details
7.7.2 FUJIFILM Diosynth Biotechnologies Major Business
7.7.3 FUJIFILM Diosynth Biotechnologies Gene Vector Product and Services
7.7.4 FUJIFILM Diosynth Biotechnologies Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.7.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.8 Spark Therapeutics, Inc.
7.8.1 Spark Therapeutics, Inc. Details
7.8.2 Spark Therapeutics, Inc. Major Business
7.8.3 Spark Therapeutics, Inc. Gene Vector Product and Services
7.8.4 Spark Therapeutics, Inc. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Spark Therapeutics, Inc. Recent Developments/Updates
7.8.6 Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Vector Industry Chain
8.2 Gene Vector Upstream Analysis
8.3 Gene Vector Midstream Analysis
8.4 Gene Vector Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Vector Introduction
1.2 World Gene Vector Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Vector Total Market by Region (by Headquarter Location)
1.3.1 World Gene Vector Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Vector Market Size (2018-2029)
1.3.3 China Gene Vector Market Size (2018-2029)
1.3.4 Europe Gene Vector Market Size (2018-2029)
1.3.5 Japan Gene Vector Market Size (2018-2029)
1.3.6 South Korea Gene Vector Market Size (2018-2029)
1.3.7 ASEAN Gene Vector Market Size (2018-2029)
1.3.8 India Gene Vector Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Vector Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Vector Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Vector Consumption Value (2018-2029)
2.2 World Gene Vector Consumption Value by Region
2.2.1 World Gene Vector Consumption Value by Region (2018-2023)
2.2.2 World Gene Vector Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Vector Consumption Value (2018-2029)
2.4 China Gene Vector Consumption Value (2018-2029)
2.5 Europe Gene Vector Consumption Value (2018-2029)
2.6 Japan Gene Vector Consumption Value (2018-2029)
2.7 South Korea Gene Vector Consumption Value (2018-2029)
2.8 ASEAN Gene Vector Consumption Value (2018-2029)
2.9 India Gene Vector Consumption Value (2018-2029)
3 WORLD GENE VECTOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Vector Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Vector Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Vector in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Vector in 2022
3.3 Gene Vector Company Evaluation Quadrant
3.4 Gene Vector Market: Overall Company Footprint Analysis
3.4.1 Gene Vector Market: Region Footprint
3.4.2 Gene Vector Market: Company Product Type Footprint
3.4.3 Gene Vector Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Vector Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Vector Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Vector Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Vector Consumption Value Comparison
4.2.1 United States VS China: Gene Vector Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Vector Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Vector Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Vector Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Vector Revenue, (2018-2023)
4.4 China Based Companies Gene Vector Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Vector Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Vector Revenue, (2018-2023)
4.5 Rest of World Based Gene Vector Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Vector Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Vector Revenue, (2018-2023)
5 MARKET ANALYSIS BY VECTOR TYPE
5.1 World Gene Vector Market Size Overview by Vector Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Vector Type
5.2.1 Lentivirus
5.2.2 Adenovirus
5.2.3 Adeno-associated Virus (AAV)
5.2.4 Plasmid DNA
5.2.5 Others
5.3 Market Segment by Vector Type
5.3.1 World Gene Vector Market Size by Vector Type (2018-2023)
5.3.2 World Gene Vector Market Size by Vector Type (2024-2029)
5.3.3 World Gene Vector Market Size Market Share by Vector Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Vector Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Scientific Research
6.2.2 CRO
6.2.3 CDMO
6.2.4 Others (Pharmaceutical, Biotechnology Companies)
6.2.5 Others (Pharmaceutical, Biotechnology Companies)
6.3 Market Segment by Application
6.3.1 World Gene Vector Market Size by Application (2018-2023)
6.3.2 World Gene Vector Market Size by Application (2024-2029)
6.3.3 World Gene Vector Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Gene Vector Product and Services
7.1.4 Lonza Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Gene Vector Product and Services
7.2.4 Merck KGaA Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Oxford Biomedica
7.3.1 Oxford Biomedica Details
7.3.2 Oxford Biomedica Major Business
7.3.3 Oxford Biomedica Gene Vector Product and Services
7.3.4 Oxford Biomedica Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Oxford Biomedica Recent Developments/Updates
7.3.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.4 CGT Catapult
7.4.1 CGT Catapult Details
7.4.2 CGT Catapult Major Business
7.4.3 CGT Catapult Gene Vector Product and Services
7.4.4 CGT Catapult Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CGT Catapult Recent Developments/Updates
7.4.6 CGT Catapult Competitive Strengths & Weaknesses
7.5 Charles River Laboratories
7.5.1 Charles River Laboratories Details
7.5.2 Charles River Laboratories Major Business
7.5.3 Charles River Laboratories Gene Vector Product and Services
7.5.4 Charles River Laboratories Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Charles River Laboratories Recent Developments/Updates
7.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.6 uniQure N.V.
7.6.1 uniQure N.V. Details
7.6.2 uniQure N.V. Major Business
7.6.3 uniQure N.V. Gene Vector Product and Services
7.6.4 uniQure N.V. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 uniQure N.V. Recent Developments/Updates
7.6.6 uniQure N.V. Competitive Strengths & Weaknesses
7.7 FUJIFILM Diosynth Biotechnologies
7.7.1 FUJIFILM Diosynth Biotechnologies Details
7.7.2 FUJIFILM Diosynth Biotechnologies Major Business
7.7.3 FUJIFILM Diosynth Biotechnologies Gene Vector Product and Services
7.7.4 FUJIFILM Diosynth Biotechnologies Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.7.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.8 Spark Therapeutics, Inc.
7.8.1 Spark Therapeutics, Inc. Details
7.8.2 Spark Therapeutics, Inc. Major Business
7.8.3 Spark Therapeutics, Inc. Gene Vector Product and Services
7.8.4 Spark Therapeutics, Inc. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Spark Therapeutics, Inc. Recent Developments/Updates
7.8.6 Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Vector Industry Chain
8.2 Gene Vector Upstream Analysis
8.3 Gene Vector Midstream Analysis
8.4 Gene Vector Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Vector Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Vector Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Vector Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Vector Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Vector Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Vector Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Vector Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Vector Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Vector Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Vector Players in 2022
Table 12. World Gene Vector Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Vector Company Evaluation Quadrant
Table 14. Head Office of Key Gene Vector Player
Table 15. Gene Vector Market: Company Product Type Footprint
Table 16. Gene Vector Market: Company Product Application Footprint
Table 17. Gene Vector Mergers & Acquisitions Activity
Table 18. United States VS China Gene Vector Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Vector Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Vector Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 23. China Based Gene Vector Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Vector Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 29. World Gene Vector Market Size by Vector Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Vector Market Size by Vector Type (2018-2023) & (USD Million)
Table 31. World Gene Vector Market Size by Vector Type (2024-2029) & (USD Million)
Table 32. World Gene Vector Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Vector Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Vector Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Gene Vector Product and Services
Table 38. Lonza Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Merck KGaA Basic Information, Area Served and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA Gene Vector Product and Services
Table 44. Merck KGaA Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Oxford Biomedica Basic Information, Area Served and Competitors
Table 48. Oxford Biomedica Major Business
Table 49. Oxford Biomedica Gene Vector Product and Services
Table 50. Oxford Biomedica Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Oxford Biomedica Recent Developments/Updates
Table 52. Oxford Biomedica Competitive Strengths & Weaknesses
Table 53. CGT Catapult Basic Information, Area Served and Competitors
Table 54. CGT Catapult Major Business
Table 55. CGT Catapult Gene Vector Product and Services
Table 56. CGT Catapult Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CGT Catapult Recent Developments/Updates
Table 58. CGT Catapult Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Area Served and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Gene Vector Product and Services
Table 62. Charles River Laboratories Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. uniQure N.V. Basic Information, Area Served and Competitors
Table 66. uniQure N.V. Major Business
Table 67. uniQure N.V. Gene Vector Product and Services
Table 68. uniQure N.V. Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. uniQure N.V. Recent Developments/Updates
Table 70. uniQure N.V. Competitive Strengths & Weaknesses
Table 71. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 72. FUJIFILM Diosynth Biotechnologies Major Business
Table 73. FUJIFILM Diosynth Biotechnologies Gene Vector Product and Services
Table 74. FUJIFILM Diosynth Biotechnologies Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 76. Spark Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 77. Spark Therapeutics, Inc. Major Business
Table 78. Spark Therapeutics, Inc. Gene Vector Product and Services
Table 79. Spark Therapeutics, Inc. Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Gene Vector Upstream (Raw Materials)
Table 81. Gene Vector Typical Customers
Table 1. World Gene Vector Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Vector Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Vector Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Vector Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Vector Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Vector Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Vector Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Vector Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Vector Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Vector Players in 2022
Table 12. World Gene Vector Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Vector Company Evaluation Quadrant
Table 14. Head Office of Key Gene Vector Player
Table 15. Gene Vector Market: Company Product Type Footprint
Table 16. Gene Vector Market: Company Product Application Footprint
Table 17. Gene Vector Mergers & Acquisitions Activity
Table 18. United States VS China Gene Vector Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Vector Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Vector Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 23. China Based Gene Vector Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Vector Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Vector Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Vector Revenue Market Share (2018-2023)
Table 29. World Gene Vector Market Size by Vector Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Vector Market Size by Vector Type (2018-2023) & (USD Million)
Table 31. World Gene Vector Market Size by Vector Type (2024-2029) & (USD Million)
Table 32. World Gene Vector Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Vector Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Vector Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Gene Vector Product and Services
Table 38. Lonza Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Merck KGaA Basic Information, Area Served and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA Gene Vector Product and Services
Table 44. Merck KGaA Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Oxford Biomedica Basic Information, Area Served and Competitors
Table 48. Oxford Biomedica Major Business
Table 49. Oxford Biomedica Gene Vector Product and Services
Table 50. Oxford Biomedica Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Oxford Biomedica Recent Developments/Updates
Table 52. Oxford Biomedica Competitive Strengths & Weaknesses
Table 53. CGT Catapult Basic Information, Area Served and Competitors
Table 54. CGT Catapult Major Business
Table 55. CGT Catapult Gene Vector Product and Services
Table 56. CGT Catapult Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CGT Catapult Recent Developments/Updates
Table 58. CGT Catapult Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Area Served and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Gene Vector Product and Services
Table 62. Charles River Laboratories Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. uniQure N.V. Basic Information, Area Served and Competitors
Table 66. uniQure N.V. Major Business
Table 67. uniQure N.V. Gene Vector Product and Services
Table 68. uniQure N.V. Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. uniQure N.V. Recent Developments/Updates
Table 70. uniQure N.V. Competitive Strengths & Weaknesses
Table 71. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 72. FUJIFILM Diosynth Biotechnologies Major Business
Table 73. FUJIFILM Diosynth Biotechnologies Gene Vector Product and Services
Table 74. FUJIFILM Diosynth Biotechnologies Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 76. Spark Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 77. Spark Therapeutics, Inc. Major Business
Table 78. Spark Therapeutics, Inc. Gene Vector Product and Services
Table 79. Spark Therapeutics, Inc. Gene Vector Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Gene Vector Upstream (Raw Materials)
Table 81. Gene Vector Typical Customers
LIST OF FIGURES
Figure 1. Gene Vector Picture
Figure 2. World Gene Vector Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Vector Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Vector Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Vector Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 13. Gene Vector Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Vector Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Vector by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Vector Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Vector Markets in 2022
Figure 27. United States VS China: Gene Vector Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Vector Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Vector Market Size by Vector Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Vector Market Size Market Share by Vector Type in 2022
Figure 31. Lentivirus
Figure 32. Adenovirus
Figure 33. Adeno-associated Virus (AAV)
Figure 34. Plasmid DNA
Figure 35. Others
Figure 36. World Gene Vector Market Size Market Share by Vector Type (2018-2029)
Figure 37. World Gene Vector Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Gene Vector Market Size Market Share by Application in 2022
Figure 39. Scientific Research
Figure 40. CRO
Figure 41. CDMO
Figure 42. Others (Pharmaceutical, Biotechnology Companies)
Figure 43. Gene Vector Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Figure 1. Gene Vector Picture
Figure 2. World Gene Vector Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Vector Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Vector Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Vector Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Vector Revenue (2018-2029) & (USD Million)
Figure 13. Gene Vector Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Vector Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Vector Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Vector by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Vector Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Vector Markets in 2022
Figure 27. United States VS China: Gene Vector Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Vector Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Vector Market Size by Vector Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Vector Market Size Market Share by Vector Type in 2022
Figure 31. Lentivirus
Figure 32. Adenovirus
Figure 33. Adeno-associated Virus (AAV)
Figure 34. Plasmid DNA
Figure 35. Others
Figure 36. World Gene Vector Market Size Market Share by Vector Type (2018-2029)
Figure 37. World Gene Vector Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Gene Vector Market Size Market Share by Application in 2022
Figure 39. Scientific Research
Figure 40. CRO
Figure 41. CDMO
Figure 42. Others (Pharmaceutical, Biotechnology Companies)
Figure 43. Gene Vector Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
